AREV Nutrition Sciences Inc. Signs Distribution Agreements with Purity Life and Natural World

Tickers: XCNQ:ARV
Tags: Mining

Vancouver, British Columbia / TheNewswire / November 28, 2017 - AREV Nutrition Sciences Inc. ("AREV" or the "Company") (CNSX - AREV), is pleased to announce they have signed a non-exclusive distribution agreement with Purity Life for the Company's line of COCO-MULSION products in Canada. With distribution centres in Acton, Ontario and Vancouver, British Columbia, Purity Life is Canada's leading distributor of natural health products and supplies the highest quality products to over 7,000 stores across the country.

Additionally, the company also signed an agreement with Natural World (Le Monde au Naturel) to promote the COCO-MULSION products in natural health food stores in Quebec. Natural World is based in Trois-Rivieres and serves hundreds of stores in all corners of the province of Quebec. Natural World is also the publisher of the Monde au Naturel Magazine, a consumer publication that is distributed to 30,000 customers throughout health food stores in the province.

COCO-MULTION ORIGINAL (NPN 80074051) and COCO-MULTION BRAIN (NPN 80073902) are Licensed Natural health Products by Health Canada. They contain a proprietary MCT and protein emulsification blend that has also been used to develop the company's CANNA-MULTION BASE Product that is sold to Pharmacists and Formulators who need to evenly disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address areas of health including but not limited to Anxiety, Pain management, Insomnia, Central Nervous System Disorders & Sexuality. The CANNA-MULTION Base enables formulators to deliver precise and safe dose of oil based extracts and isolates.

"We are very excited to have both Purity Life and Natural World as distribution partners. They have a solid reputation and extensive experience in the natural health industry, and are confident that they will provide the best exposure for the COCO-MULSION products," says Stephane Maher, CEO of AREV Nutrition Sciences Inc.

For further information, contact Stephane Maher, CEO at stephane@arevnutrition.com.

On behalf of the Board,


Stephane Maher
Chief Executive Officer & Director

About AREV Nutrition Sciences Inc. www.arevnutrition.com
AREV Nutrition Sciences Inc. ("AREV"), produces and delivers functional ingredients from its world-class extraction system. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain management, Insomnia, Central Nervous System Disorders & Sexuality.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com.

Copyright (c) 2017 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.